Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly puts two-thirds of midphase cancer pipeline up for sale in major shake-up of R&D priorities
Lilly puts two-thirds of midphase cancer pipeline up for sale in major shake-up of R&D priorities
Lilly puts two-thirds of midphase cancer pipeline up for sale in major shake-up of R&D priorities
Submitted by
admin
on July 25, 2017 - 10:27am
Source:
Fierce Biotech
News Tags:
Eli Lilly
M&A
oncology
R&D
Headline:
Lilly puts two-thirds of midphase cancer pipeline up for sale in major shake-up of R&D priorities
Do Not Allow Advertisers to Use My Personal information
